Follow
A. T. Cohen
A. T. Cohen
Consultant Vascular Physician, Guy's and St Thomas' Hospitals NHS Foundation Trust
Verified email at KCL.AC.UK
Title
Cited by
Cited by
Year
Oral apixaban for the treatment of acute venous thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, ...
N engl j med 369, 799-808, 2013
25202013
Venous thromboembolism (VTE) in Europe
AT Cohen, G Agnelli, FA Anderson, JI Arcelus, D Bergqvist, JG Brecht, ...
Thrombosis and haemostasis 98 (10), 756-764, 2007
21112007
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
HR Büller, MH Prins, AWA Lensing, H Decousus, BF Jacobson, E Minar, ...
The New England journal of medicine 366 (14), 1287-97, 2012
20972012
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
MM Samama, AT Cohen, JY Darmon, L Desjardins, A Eldor, C Janbon, ...
New England Journal of Medicine 341 (11), 793-800, 1999
20681999
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
AT Cohen, VF Tapson, JF Bergmann, SZ Goldhaber, AK Kakkar, ...
The lancet 371 (9610), 387-394, 2008
18222008
Apixaban for extended treatment of venous thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, A Porcari, ...
N Engl J Med 368, 699-708, 2013
15302013
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer
D Bergqvist, G Agnelli, AT Cohen, A Eldor, PE Nilsson, ...
New England Journal of Medicine 346 (13), 975-980, 2002
13252002
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
A Leizorovicz, AT Cohen, AGG Turpie, CG Olsson, PT Vaitkus, ...
Circulation 110 (7), 874-879, 2004
11692004
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
AT Cohen, BL Davidson, AS Gallus, MR Lassen, MH Prins, W Tomkowski, ...
Bmj 332 (7537), 325-329, 2006
10092006
Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ...
New England Journal of Medicine 375 (12), 1131-1141, 2016
8572016
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
Einstein–PE Investigators
New England Journal of Medicine 366 (14), 1287-1297, 2012
7232012
Rivaroxaban or aspirin for extended treatment of venous thromboembolism
JI Weitz, AWA Lensing, MH Prins, R Bauersachs, J Beyer-Westendorf, ...
New England Journal of Medicine 376 (13), 1211-1222, 2017
7082017
Rivaroxaban for thromboprophylaxis in acutely ill medical patients
AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...
N engl j med 368, 513-523, 2013
6882013
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study
R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, ...
Archives of internal medicine 164 (9), 963-968, 2004
6852004
Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors
SJ Connolly, M Crowther, JW Eikelboom, CM Gibson, JT Curnutte, ...
New England Journal of Medicine 380 (14), 1326-1335, 2019
6512019
Apixaban for the treatment of venous thromboembolism associated with cancer
G Agnelli, C Becattini, G Meyer, A Muñoz, MV Huisman, JM Connors, ...
New England Journal of Medicine, 2020
6432020
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
MH Prins, AWA Lensing, R Bauersachs, B Van Bellen, H Bounameaux, ...
Thrombosis journal 11, 1-10, 2013
6162013
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
VV Kakkar, AT Cohen, RA Edmonson, MJ Phillips, SK Das, KT Maher, ...
The Lancet 341 (8840), 259-265, 1993
5091993
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs antistreplase and of aspirin plus heparin vs aspirin along among 41 299 cases of suspected …
D Hunt, J Varigos, F Dienstl, P Lechleitner, G De Backer, M KORNITZER, ...
Lancet 339 (8796), 753-770, 1992
5031992
Extended thromboprophylaxis with betrixaban in acutely ill medical patients
AT Cohen, RA Harrington, SZ Goldhaber, RD Hull, BL Wiens, A Gold, ...
New England Journal of Medicine 375 (6), 534-544, 2016
4642016
The system can't perform the operation now. Try again later.
Articles 1–20